We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$185M
AUM Growth
+$6.35M
Cap. Flow
-$4.39M
Cap. Flow %
-2.37%
Top 10 Hldgs %
41.23%
Holding
94
New
5
Increased
11
Reduced
47
Closed
4

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$3.93M
2
ACN icon
Accenture
ACN
+$492K
3
COF icon
Capital One
COF
+$275K
4
APA icon
APA Corp
APA
+$109K
5
PM icon
Philip Morris
PM
+$67.8K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.7M
2
COO icon
Cooper Companies
COO
+$1.02M
3
STZ icon
Constellation Brands
STZ
+$769K
4
AAPL icon
Apple
AAPL
+$397K
5
EXAS
Exact Sciences
EXAS
+$317K

Sector Composition

Rank Sector Weight
1 Technology 19.95%
2 Industrials 19.83%
3 Financials 19.25%
4 Healthcare 14.29%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$14.4M 7.76%
70,030
-1,968
-3% -$397K
GS icon
2
Goldman Sachs
GS
$300B
$11.2M 6.06%
15,853
-409
-3% -$237K
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.36T
$9.87M 5.33%
55,616
-1,450
-3% -$240K
BN icon
4
Brookfield
BN
$104B
$7.45M 4.02%
180,588
-5,204
-3% -$193K
TEL icon
5
TE Connectivity
TEL
$59.6B
$5.97M 3.23%
35,398
-1,250
-3% -$190K
BA icon
6
Boeing
BA
$171B
$5.95M 3.22%
28,411
-860
-3% -$162K
CM icon
7
Canadian Imperial Bank of Commerce
CM
$108B
$5.83M 3.15%
82,240
-3,470
-4% -$223K
HSY icon
8
Hershey
HSY
$35.2B
$5.31M 2.87%
31,989
-231
-0.7% -$38.1K
EMR icon
9
Emerson Electric
EMR
$83.9B
$5.27M 2.85%
39,540
-2,680
-6% -$307K
SNA icon
10
Snap-on
SNA
$21.2B
$5.07M 2.74%
16,285
-465
-3% -$148K
ABBV icon
11
AbbVie
ABBV
$443B
$4.53M 2.45%
24,385
-450
-2% -$83.6K
MOS icon
12
The Mosaic Company
MOS
$7.03B
$4.34M 2.35%
119,110
-435
-0.4% -$13.9K
DHR icon
13
Danaher
DHR
$137B
$4.18M 2.26%
21,148
-575
-3% -$112K
YUM icon
14
Yum! Brands
YUM
$41.8B
$4.15M 2.24%
28,002
-1,330
-5% -$194K
RTX icon
15
RTX Corp
RTX
$290B
$3.95M 2.13%
27,024
-765
-3% -$102K
TMO icon
16
Thermo Fisher Scientific
TMO
$213B
$3.81M 2.06%
+9,404
New +$3.93M
DE icon
17
Deere & Co
DE
$160B
$3.79M 2.05%
7,460
-314
-4% -$154K
ETN icon
18
Eaton
ETN
$161B
$3.63M 1.96%
10,167
-765
-7% -$236K
JKHY icon
19
Jack Henry & Associates
JKHY
$10.9B
$3.56M 1.92%
19,740
-470
-2% -$83.5K
MAS icon
20
Masco
MAS
$14.1B
$3.44M 1.86%
53,470
+95
+0.2% +$5.98K
MS icon
21
Morgan Stanley
MS
$331B
$3.26M 1.76%
23,127
+2
+0% +$246
OKE icon
22
Oneok
OKE
$57.2B
$3.02M 1.63%
36,992
-490
-1% -$40.9K
MSFT icon
23
Microsoft
MSFT
$3.45T
$2.97M 1.61%
5,978
– –
BAM icon
24
Brookfield Asset Management
BAM
$77.3B
$2.65M 1.43%
48,015
-476
-1% -$25.6K
V icon
25
Visa
V
$684B
$2.64M 1.43%
7,428
-50
-0.7% -$17.4K
1
2 3 4

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Lipe & Dalton's Q2 2025 Portfolio in Review

As of Q2 2025, Lipe & Dalton held 94 positions worth $185M, up 3.6% from $179M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Lipe & Dalton's Q2 2025 filing shows 5 new, 11 increased, 47 reduced and 4 closed positions. Its largest new stake was Thermo Fisher Scientific: 9,404 shares worth $3.81M. The largest sale was Bristol-Myers Squibb, an estimated $2.7M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.

  • Lipe & Dalton's largest Q2 2025 buy was Thermo Fisher Scientific: 9,404 shares worth $3.81M.
  • Lipe & Dalton added most to Accenture in Q2 2025, an estimated $492K increase.
  • Lipe & Dalton's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $2.7M.
  • Lipe & Dalton fully exited Cooper Companies in Q2 2025, selling an estimated $1.02M.
  • Lipe & Dalton's ten largest holdings make up 41% of its $185M portfolio in Q2 2025.
  • Lipe & Dalton opened 5 new positions and closed 4 in Q2 2025.
  • Lipe & Dalton's portfolio value rose 3.6% quarter-over-quarter to $185M.

Based on Lipe & Dalton's 13F filing for Q2 2025, filed 1 Aug 2025.